Archived:MiT family translocation carcinomas: Difference between revisions
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
No edit summary |
Bailey.Glen (talk | contribs) m Bailey.Glen moved page MiT family translocation carcinomas to Archived:MiT family translocation carcinomas without leaving a redirect: Moved to Archive |
||
(No difference)
| |||
Latest revision as of 16:33, 6 October 2025
 | This page is under construction |
Contributors
Tumor Type
Tumor Classification
Description
IHC Markers
Genomic Gain/Loss/LOH
| Chromosome | Gain/Loss/Amp | Region |
|---|---|---|
| 1 | Loss | Chr1 |
| 2 | Loss | Chr14 |
| 3 | Loss | Chr21 |
| 4 | Loss | ChrX |
| 5 | Loss | ChrY (male) |
Rearrangements
Mutations (SNV/INDEL)
From Cosmic Mutated in >20%
Mutated in 10-20%
Mutated in 5-10%
Mutated in 2-5%
mtDNA
Epigenomics (methylation)
Main Pathways Involved
Diagnosis
Prognosis
Therapeutics
Write your comments here